Success Story: NIW Approved Without RFE! We Helped a Resident From Pakistan Secure Success with Premium Processing Service
Client’s Testimonial:
"Thank you for all the support and guidance."
On January 12th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Resident in the Field of Internal Medicine (Approval Notice).
General Field: Internal Medicine
Position at the Time of Case Filing: Resident
Country of Origin: Pakistan
State of Residence at the Time of Filing: Pennsylvania
Approval Notice Date: January 12th, 2026
Processing Time: 1 month, 26 days (Premium Processing Requested)
Case Summary:
We are pleased to share the success of an EB-2 NIW (National Interest Waiver) petition for a physician researcher in the field of internal medicine. The client, who holds an M.B.B.S. degree, secured approval by demonstrating that their work possesses both substantial merit and national importance to the United States. North America Immigration Law Group (NAILG) successfully argued that the client’s contributions to advancing diagnostic and therapeutic strategies for autoimmune and systemic diseases address critical national needs regarding public health and healthcare economics.
Research Focus and National Importance
The client’s proposed endeavor focuses on conducting retrospective and prospective studies in clinical medicine and rheumatology to enable earlier diagnosis and treatment. As an expert in internal medicine, the client investigates complex disease manifestations, including Melanoma differentiation-associated protein 5 (MDA5), associated with rapidly progressive interstitial lung disease and idiopathic inflammatory myositis. This research is designed to improve patient outcomes by refining diagnostic accuracy and therapeutic protocols for severe autoimmune disorders.
NAILG highlighted that this work aligns with U.S. national priorities to reduce the burden of chronic diseases. Specifically, the petition emphasized the economic and health impact of conditions like rheumatoid arthritis, which costs the U.S. billions annually in direct medical expenses and lost productivity. By advancing early detection methods, the client’s research supports national goals to lower healthcare costs and minimize long-term disability for millions of Americans.
Demonstrating Influence Through Clinical Impact
To demonstrate that the client is well-positioned to advance this endeavor, we presented a documented record of scholarly and clinical success. The client has authored 11 peer-reviewed journal articles (3 of them first-authored), 7 conference abstracts (2 of them first-authored), and 1 first-authored preprint.
While the citation count was 60 citations, we provided crucial context to demonstrate the high relative impact of this work. We showed that one of the client’s papers on COVID-19 complications ranked among the top 10% most cited articles in the field of Clinical Medicine for its year of publication. This qualitative analysis proved that the client’s findings on anticoagulant therapy and disease management are widely relied upon by the medical community to improve clinical care guidelines.
The Result
By effectively framing the client’s clinical research within the broader context of U.S. public health priorities and using citation percentiles to validate their influence, we built a persuasive case. The petition was approved under Direct Premium Processing, affirming the national significance of the client’s work in improving diagnostic precision and patient care. We are proud to have assisted this dedicated physician-researcher in securing their NIW approval.